GH Research (GHRS) Capital Expenditures (2021 - 2025)
GH Research's (GHRS) quarterly Capital Expenditures came in at -$19000.0 in Q4 2025, up 24.0% year-on-year from -$15322.6 in Q4 2024, and up 51.28% quarter-over-quarter from -$39000.0 in Q3 2025.
GH Research (GHRS) Capital Expenditures (2021 - 2025) Analysis & Trends
GH Research's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$19000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 24.0% year-over-year to -$19000.0 in Q4 2025; TTM through Dec 2025 was -$121000.0, a 146.94% decrease from a year earlier, with the FY2025 full-year figure at -$121000.0, down 146.94% from the prior year.
- Capital Expenditures improved to -$19000.0 in Q4 2025 per GHRS's latest filing, from -$39000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $189000.0 in Q4 2021 and bottomed at -$59000.0 in Q2 2025.
- The 5-year median for Capital Expenditures is -$14500.0 (2021), against an average of $5050.0.
- Across the five-year window, Capital Expenditures soared 82.61% in 2024 and tumbled 875.0% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $189000.0 in 2021, then sank by 38.62% to $116000.0 in 2022, then soared by 51.72% to $176000.0 in 2023, then sank by 114.2% to -$25000.0 in 2024, then increased by 24.0% to -$19000.0 in 2025.
- Per Business Quant, the three latest GHRS Capital Expenditures figures stand at -$19000.0 (Q4 2025), -$39000.0 (Q3 2025), and -$59000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |